Akebia Therapeutics Inc.

NASDAQ: AKBA · Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT

Akebia Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.41M -51.92M -92.56M -282.84M
Depreciation & Amortization
37.5M 41.85M 37.7M 37.97M
Stock-Based Compensation
7.78M 9.32M 17.85M 22.73M
Other Working Capital
-13.96M -13.94M -34.42M -46.81M
Other Non-Cash Items
23.15M -1.9M -34.7M 41.01M
Deferred Income Tax
n/a n/a n/a 36.58M
Change in Working Capital
-39.68M -20.73M -1.44M -108.42M
Operating Cash Flow
-40.66M -23.38M -73.15M -252.97M
Capital Expenditures
-33K n/a -114K -59K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 40M
Other Investing Acitivies
n/a n/a n/a 40M
Investing Cash Flow
-33K n/a -114K 39.94M
Debt Repayment
7.9M -32M -33M n/a
Common Stock Repurchased
-1.27M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
385K 1K 40.07M 133.73M
Financial Cash Flow
49.66M -25.21M 14.6M 133.73M
Net Cash Flow
8.97M -48.59M -58.67M -79.29M
Free Cash Flow
-40.69M -23.38M -73.27M -253.02M